These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 28350098)
1. SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway. Zhu B; Cheng D; Hou L; Zhou S; Ying T; Yang Q Oncol Rep; 2017 May; 37(5):2575-2582. PubMed ID: 28350098 [TBL] [Abstract][Full Text] [Related]
2. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway. Hao L; Liao Q; Tang Q; Deng H; Chen L Biochem Biophys Res Commun; 2016 Feb; 470(3):643-649. PubMed ID: 26797271 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma. Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383 [TBL] [Abstract][Full Text] [Related]
4. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis. Zhu B; Cheng D; Li S; Zhou S; Yang Q Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247 [TBL] [Abstract][Full Text] [Related]
5. SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling. Liu X; Zhou X; Xu H; He Z; Shi X; Wu S DNA Cell Biol; 2017 Sep; 36(9):775-780. PubMed ID: 28777670 [TBL] [Abstract][Full Text] [Related]
6. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling. Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727 [TBL] [Abstract][Full Text] [Related]
7. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257 [TBL] [Abstract][Full Text] [Related]
8. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells. Yang J; Zou Y; Jiang D Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336 [TBL] [Abstract][Full Text] [Related]
9. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway. Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480 [TBL] [Abstract][Full Text] [Related]
10. The expression and function of miRNA-106 in pediatric osteosarcoma. Xu M; Zhang YY; Wang HF; Yang GS Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway. Zhao X; Fang Y; Wang X; Yang Z; Li D; Tian M; Kang P Int J Oncol; 2020 Jan; 56(1):206-218. PubMed ID: 31746363 [TBL] [Abstract][Full Text] [Related]
12. RNF135 Promotes Human Osteosarcoma Cell Growth and Inhibits Apoptosis by Upregulating the PI3K/AKT Pathway. Chen B; Zhang Y; Song G; Wei X Cancer Rep (Hoboken); 2024 Aug; 7(8):e2159. PubMed ID: 39118262 [TBL] [Abstract][Full Text] [Related]
13. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway. Xiao J; Yu W; Hu K; Li M; Chen J; Li Z Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104 [TBL] [Abstract][Full Text] [Related]
14. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture. Ye K; Wang S; Yang Y; Kang X; Wang J; Han H Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148 [TBL] [Abstract][Full Text] [Related]
15. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway. Li YJ; Dong BK; Fan M; Jiang WX Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427 [TBL] [Abstract][Full Text] [Related]
16. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro. Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910 [TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma. Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway. Zhu LB; Jiang J; Zhu XP; Wang TF; Chen XY; Luo QF; Shu Y; Liu ZL; Huang SH Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775 [TBL] [Abstract][Full Text] [Related]
19. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway. Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway. Da W; Tao L; Zhu Y Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]